With $ 14 million Series B funding, Lumiata puts healthcare data in the hands of physicians, health systems and payers so they can identify risks and reduce costs.
Subscribe to the Crunchbase Daily
The San Mateo, Calif., Based company says it can take healthcare-specific datasets and prepare them for machine learning in weeks using a little-to-no code-based process. in the cloud and integrating with existing systems. Once the data is analyzed using artificial intelligence, Lumiata claims to be able to identify underwriting risks and better understand cost reduction to make reliable predictions on health outcomes.
Defy.vc and AllegisNL Capital led the company’s new financing and were joined by existing investors Khosla Ventures and Blue Venture Fund.
Including Series B, Lumiata has raised around $ 50 million in total since its inception in 2013, Lumiata CEO Dilawar Syed told Crunchbase News. Syed joined the company in 2018.
“Lumiata was one…
News Highlights Finance
- According to the source Lumiata closes $ 14 million Series B to predict healthcare outcomes – crunchbase news
- Check all news and articles from the Health news information updates.